@zararaye_'s hair growth claims need more context
Quick answer
The transcript provides no substantive clinical claims, capturing only filler audio from a video categorized under peptide therapy with a hair growth transformation framing. Based on the video category and hashtags, the implied clinical territory involves systemic or topical peptide use for hair growth, an area where preclinical data exists primarily for GHK-Cu but human clinical evidence remains limited across the peptide class. Any patient interested in this approach should have a baseline workup to rule out treatable causes of hair loss before pursuing off-label peptide protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @zararaye_ actually say?
Honestly, not much we can work with. The transcript captured from this video is almost entirely filler: "Yeah. Alright. Alright. Alright. Alright. Okay. So You" — and then nothing. That's it. Whatever @zararaye_ was documenting about a five-month hair growth journey, the words didn't make it into the transcript we have to work with.
The video is categorized under peptide therapy, and the hashtags point clearly to a hair transformation narrative. So the implied claim is that something, probably a peptide or peptide-adjacent protocol, drove meaningful hair growth over five months. But we can't quote the creator on specifics because the transcript doesn't give us any.
We're going to assess the broader category of claims this kind of video typically makes, and what the evidence actually says about peptides and hair growth.
Does the science back up peptides for hair growth?
The short answer: it depends heavily on which peptide you're talking about, and the human evidence is thinner than most TikTok content implies. GHK-Cu (copper peptide) has the most studied track record for hair, and even that evidence has significant limits.
A 1993 study by Uno and colleagues, published in Skin Pharmacology, found GHK-Cu stimulated hair follicle enlargement in a scalp organ culture model. More recently, a 2018 paper in the Journal of Cosmetic Dermatology by Gorouhi and Maibach reviewed copper peptides in skin and hair, noting promising preclinical findings but calling the clinical data "insufficient for definitive conclusions." That's the honest read.
BPC-157, another peptide popular in this space, has shown angiogenic effects in animal studies, which theoretically could support follicle health through improved blood supply. But published human trials on BPC-157 for hair specifically? They don't exist yet. MK-677 raises IGF-1 levels, and IGF-1 does play a role in the anabolic phase of hair cycling, but the jump from "raises IGF-1" to "grows your hair back" involves several assumptions the data doesn't yet support.
What did they get wrong, or right?
We can't credit or correct @zararaye_ on specifics without a real transcript. What we can say is that five-month before-and-after hair videos, regardless of what protocol they're using, routinely confuse correlation with causation.
Hair grows roughly half an inch per month on average, so five months of normal growth already produces visible change. Shedding cycles also mean that someone who stops a stressor, corrects a nutritional deficiency, or simply reduces inflammation might see a rebound that looks dramatic on video but isn't a peptide effect at all.
If the creator is attributing their results to a specific peptide stack without controlling for diet, stress, sleep, or whether they previously had a deficiency, that's a methodological problem. One person's five-month journey is not a clinical trial. It's an anecdote, and anecdotes mislead people into spending money on compounds that haven't been proven safe or effective for this use in humans.
What should you actually know?
If you're curious about peptides and hair growth, here's what the evidence actually supports right now. GHK-Cu applied topically has the most backing for scalp use, though the studies are small. Systemic peptide use for hair, meaning injections or oral peptides like MK-677, operates largely on mechanistic plausibility rather than proven outcomes in humans.
Hair loss has well-established, FDA-approved treatments: minoxidil and finasteride for androgenetic alopecia, with solid trial data behind them. Before chasing a peptide protocol based on a TikTok transformation video, it's worth asking whether a basic workup has been done: ferritin, thyroid function, androgens, vitamin D. Many dramatic hair "recoveries" documented online are simply the resolution of a correctable deficiency.
A telehealth provider can help you figure out whether peptides are even appropriate for your specific situation, what compounds have any real evidence behind them, and how to think about safety given that most peptides for this use are off-label and unregulated for hair indications specifically.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @zararaye_'s hair growth claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@zararaye_'s hair growth claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The transcript provides no substantive clinical claims, capturing only filler audio from a video categorized under peptide therapy with a hair growth transformation framing.
FormBlends verdict
The transcript provides no substantive clinical claims, capturing only filler audio from a video categorized under peptide therapy with a hair growth transformation framing. Based on the video category and hashtags, the implied clinical territory involves systemic or topical peptide use for hair growth, an area where preclinical data exists primarily for GHK-Cu but human clinical evidence remains limited across the peptide class. Any patient interested in this approach should have a baseline workup to rule out treatable causes of hair loss before pursuing off-label peptide protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The transcript provides no substantive clinical claims, capturing only filler audio from a video categorized under peptide therapy with a hair growth transformation framing. Based on the video category and hashtags, the implied clinical territory involves systemic or topical peptide use for hair growth, an area where preclinical data exists primarily for GHK-Cu but human clinical evidence remains limited across the peptide class. Any patient interested in this approach should have a baseline workup to rule out treatable causes of hair loss before pursuing off-label peptide protocols.
- GHK-Cu (copper peptide) has the most published support for hair follicle effects, but a 2018 Gorouhi and Maibach review in the Journal of Cosmetic Dermatology concluded clinical evidence remains insufficient for definitive conclusions.
- Human hair grows roughly 0.5 inches per month on average, meaning five months of normal growth produces visible change without any intervention.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- GHK-Cu (copper peptide) has the most published support for hair follicle effects, but a 2018 Gorouhi and Maibach review in the Journal of Cosmetic Dermatology concluded clinical evidence remains insufficient for definitive conclusions.
- Human hair grows roughly 0.5 inches per month on average, meaning five months of normal growth produces visible change without any intervention.
- No peer-reviewed randomized controlled trials currently confirm that BPC-157, TB-500, or MK-677 produce statistically significant hair regrowth in humans.
- IGF-1, which MK-677 elevates, plays a role in the anagen phase of hair cycling, but elevated IGF-1 levels have not been proven to translate into meaningful clinical hair growth outcomes.
- FDA-approved treatments for androgenetic alopecia, minoxidil and finasteride, have substantially more clinical trial evidence than any peptide currently marketed for hair growth.
- Before attributing hair changes to a peptide, basic labs including ferritin, TSH, and vitamin D should be checked, since deficiency correction is a common and overlooked explanation for dramatic hair recovery stories.
- Single-subject TikTok transformation videos cannot establish what caused a result. They document a timeline, not a mechanism.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Zara Raye · TikTok creator
12.2K views on this video
5 month hair growth journey #hairtransformation #hairjourney #hairgrowth
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Zara Raye, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.